Role of Thromboxane A₂ Receptor on the Effects of Oxidized LDL on Microvascular Endothelium Nitric Oxide, Endothelin-1, and IL-6 Production

REFERENCES

• Abarquez R F, Jr. Microvascular disease relevance in the hypertension syndrome. Clin Hemorheol Microcirc 2003; 29: 295–300
   Google Scholar
• Ades E W, Candal F J, Swerlick R A, George V G, Summers S, Bosse D C, Lawley T J. HMEC-1: establishment of an immortalized human microvascular endothelial cell line. J Invest Dermatol 1992; 99: 683–690
   PubMed Web of Science ®Google Scholar
• Ashton A W, Cheng Y, Helisch A, Ware J A. Thromboxane A2 receptor agonists antagonize the proangiogenic effects of fibroblast growth factor-2: role of receptor internalization, thrombospondin-1, and alpha(v)beta-3. Circ Res 2004; 94: 735–742
   Google Scholar
• Assaloni R, Da Ros R, Quagliaro L, Piconi L, Maier A, Zuodar G, Motz E, Ceriello A. Effects of S21403 (mitiglinide) on postprandial generation of oxidative stress and inflammation in type 2 diabetic patients. Diabetologia 2005; 48: 1919–1924
   PubMed Web of Science ®Google Scholar
• Bloodsworth A, O'Donnell V B, Freeman B A. Nitric oxide regulation of free-radical- and enzyme-mediated lipid and lipoprotein oxidation. Arterioscler Thromb Vasc Biol 2000; 20: 1707–1715
   PubMed Web of Science ®Google Scholar
• Boulanger C M, Tanner F C, Bea M L, Hahn A W, Werner A, Luscher T F. Oxidized low-density lipoproteins induce mRNA expression and release of endothelin from human and porcine endothelium. Circ Res 1992; 70: 1191–1197
   PubMed Web of Science ®Google Scholar
• Cominacini L, Rigoni A, Pasini A F, Garbin U, Davoli A, Campagnola M, Pastorino A M, Lo Cascio V, Sawamura T. The binding of oxidized low density lipoprotein (ox-LDL) to Ox-LDL receptor-1 reduces the intracellular concentration of nitric oxide in endothelial cells through an increased production of superoxide. J Biol Chem 2001; 276: 13750–13755
   PubMed Web of Science ®Google Scholar
• Cracowski J L, Devillier P, Durand T, Stanke-Labesque F, Bessard G. Vascular biology of the isoprostanes. J Vasc Res 2001; 38: 93–103
   PubMed Web of Science ®Google Scholar
• Esterbauer H, Cheeseman K. Determination of aldehyde lipid peroxidation products: malonaldehyde and 4-hydroxinonenal. Meth Enzymol 1990; 186: 407–421
   PubMed Web of Science ®Google Scholar
• Fleming I, Mohamed A, Galle J, Turchanowa L, Brandes R P, Fisslthaler B, Busse R. Oxidized low-density lipoprotein increases superoxide production by endothelial nitric oxide synthase by inhibiting PKCalpha. Cardiovasc Res 2005; 65: 897–906
   PubMed Web of Science ®Google Scholar
• Freyschuss A, Xiu R J, Zhang J, Ying X, Diczfalusy U, Jogestrand T, Henriksson P, Bjorkhem I. Vitamin C reduces cholesterol-induced microcirculatory changes in rabbits. Arterioscler Thromb Vasc Biol 1997; 17: 1178–1184
   Google Scholar
• Go Y M, Levonen A L, Moellering D, Ramachandran A, Patel R P, Jo H, Darley-Usmar V M. Endothelial NOS-dependent activation of c-Jun NH(2)-terminal kinase by oxidized low-density lipoprotein. Am J Physiol Heart Circ Physiol 2001; 281: H2705–H2713
   Google Scholar
• Green L, Wagner D, Glogowski J, Skipper P, Wishnok J, Tannenbaum S. Analysis of nitrite, nitrate, and [15N]nitrate in biological fluids. Anal Biochem 1982; 126: 131–138
   PubMed Web of Science ®Google Scholar
• He Z, King G L. Microvascular complications of diabetes. Endocrinol Metab Clin North Am 2004; 33: 215–238, xi–xii
   PubMed Web of Science ®Google Scholar
• Hirata K, Niki N, Kuroda Y, Sakoca T, Kawashima S, Yokoyama M. Low concentration of oxidised low-density lipoprotein and lysophosphatdylcholine upregulate constitutive nitric-oxide synthase mRNA expression in bovine aortic endothelial cells. Circ Res 1995; 76: 958–962
   PubMedGoogle Scholar
• Horio T, Kohno M, Yasunari K, Murakawa K, Yokokawa K, Ikeda M, Fukui T, Takeda T. Stimulation of endothelin-1 release by low-density and very-low-density lipoproteins in cultured human endothelial cells. Atherosclerosis 1993; 101: 185–190
   PubMed Web of Science ®Google Scholar
• Hulthe J, Fagerberg B. Circulating oxidized LDL is associated with subclinical atherosclerosis development and inflammatory cytokines (AIR Study). Arterioscler Thromb Vasc Biol 2002; 22: 1162–1167
   PubMed Web of Science ®Google Scholar
• Itabe H, Ueda M. Measurement of plasma oxidized low-density lipoprotein and its clinical implications. J Atheroscler Thromb 2007; 14: 1–11
   PubMed Web of Science ®Google Scholar
• Khan M, Pelengaris S, Cooper M, Smith C, Evan G, Betteridge J. Oxidised lipoproteins may promote inflammation through the selective delay of engulfment but not binding of apoptotic cells by macrophages. Atherosclerosis 2003; 171: 21–29
   Google Scholar
• Kumar A, Kingdon E, Norman J. The isoprostane 8-iso-PGF2 alpha suppresses monocyte adhesion to human microvascular endothelial cells via two independent mechanisms. Faseb J 2005; 19: 443–445
   Google Scholar
• Liao K, Shin W, Lee W, Clark S. Oxidized low-density lipoprotein decreases the expression of endothelial nitric oxide synthase. J Biol Chem 1995; 270: 319–324
   PubMed Web of Science ®Google Scholar
• Lu Q, Bjorkhem I, Wretlind B, Diczfalusy U, Henriksson P, Freyschuss A. Effect of ascorbic acid on microcirculation in patients with Type II diabetes: a randomized, placebo-controlled, cross-over study. Clin Sci (Lond) 2005; 108: 507–513
   Web of Science ®Google Scholar
• Lubrano V, Vassalle C, Blandizzi C, Del Tacca M, Palombo C, L'Abbate A, Baldi S, Natali A. The effect of lipoproteins on endothelial nitric oxide synthase is modulated by lipoperoxides. Eur J Clin Invest 2003; 33: 117–125
   PubMed Web of Science ®Google Scholar
• Ma F X, Zhou B, Chen Z, Ren Q, Lu S H, Sawamura T, Han Z C. Oxidized low density lipoprotein impairs endothelial progenitor cells by regulation of endothelial nitric oxide synthase. J Lipid Res 2006; 47: 1228–1237
   Google Scholar
• Mehta J L, Li D Y, Chen H J, Joseph J, Romeo F. Inhibition of LOX-1 by statins may regulate to upregulation of eNOS. Biochem Ciophys Res Commun 2001; 289: 857–861
   PubMed Web of Science ®Google Scholar
• Morris S M, Jr., Billiar T R. New insights into the regulation of inducible nitric oxide synthesis. Am J Physiol 1994; 266: E829–E839
   PubMed Web of Science ®Google Scholar
• Morrow J D, Hill K E, Burk R F, Nammour T M, Badr K F, Roberts L J, 2nd. A series of prostaglandin F2-like compounds are produced in vivo in humans by a noncyclo-oxygenase, free-radical-catalyzed mechanism. Proc Natl Acad Sci U S A 1990; 87: 9383–9387
   PubMed Web of Science ®Google Scholar
• Mourad J J, Laville M. Is hypertension a tissue perfusion disorder? Implications for renal and myocardial perfusion. J Hypertens Suppl 2006; 24: S10–S16
   Google Scholar
• Niemann B, Rohrbach S, Catar R A, Muller G, Barton M, Morawietz H. Native and oxidized low-density lipoproteins stimulate endothelin-converting enzyme-1 expression in human endothelial cells. Biochem Biophys Res Commun 2005; 334: 747–753
   Google Scholar
• O'Rourke M F, Safar M E. Relationship between aortic stiffening and microvascular disease in brain and kidney: cause and logic of therapy. Hypertension 2005; 46: 200–204
   PubMed Web of Science ®Google Scholar
• Raychowdhury M K, Yukawa M, Collins L J, McGrail S H, Kent K C, Ware J A. Alternative splicing produces a divergent cytoplasmic tail in the human endothelial thromboxane A2 receptor. J Biol Chem 1995; 270: 7011
   Google Scholar
• Sakurai K, Cominacini L, Garbin U, Fratta Pasini A, Sasaki N, Takuwa Y, Masaki T, Sawamura T. Induction of endothelin-1 production in endothelial cells via cooperative action between CD40 and lectin-like oxidized LDL receptor (LOX-1). J Cardiovasc Pharmacol 2004; 44: S173–S180
   Google Scholar
• Serne E H, de Jongh R T, Eringa E C, Ijzerman R G, de Boer M P, Stehouwer C D. Microvascular dysfunction: causative role in the association between hypertension, insulin resistance and the metabolic syndrome?. Essays Biochem 2006; 42: 163–176
   Google Scholar
• Steffan Y, Jung T, Klotz L O, Schewe T, Grune T, Sies H. Protein modification elicited by oxidized low-density lipoprotein (LDL) in endothelial cells: protection by (−)-epicatechin. Free Radic Biol Med 2007; 42: 955–970
   Google Scholar
• Stepp D W, Ou J, Ackerman A W, Welak S, Klick D, Pritchard K A, Jr. Native LDL and minimally oxidized LDL differentially regulate superoxide anion in vascular endothelium in situ. Am J Physiol Heart Circ Physiol 2002; 283: H750–H759
   Google Scholar
• Stokes K, Cooper D, Tailor A, Granger D. Hypercholesterolemia promotes inflammation and microvascular dysfunction: role of nitric oxide and superoxide. Free Radic Biol Med 2002; 33: 1026–1036
   PubMed Web of Science ®Google Scholar
• Takabe W, Kanai Y, Chairoungdua A, Shibata N, Toi S, Kobayashi M, Kodama T, Noguchi N. Lysophosphatidylcholine enhances cytokine production of endothelial cells via induction of L-type amino acid transporter 1 and cell-surface antigen 4F2. Arterioscler Thromb Vasc Biol 2004; 24: 1640–1645
   Google Scholar
• Tanner F C, Noll G, Boulanger C M, Luscher T F. Oxidized low-density lipoproteins inhibit relaxations of porcine coronary arteries. Role of scavenger receptor and endothelium-derived nitric oxide. Circulation 1991; 83: 2012–2020
   PubMed Web of Science ®Google Scholar
• Yoshida H, Sasaki K, Namiki Y, Sato N, Tada N. Edaravone, a novel radical scavenger, inhibits oxidative modification of low-density lipoprotein (LDL) and reverses oxidized LDL-medicated reduction in the expression and endothelial nitric oxide synthase. Atheroschlerosis 2005; 179: 97–102
   PubMed Web of Science ®Google Scholar
• Yura T, Fukunaga M, Khan R, Nassar G N, Badr K F, Montero A. Free-radical-generated F2-isoprostane stimulates cell proliferation and endothelin-1 expression on endothelial cells. Kidney Int 1999; 56: 471–478
   PubMed Web of Science ®Google Scholar
• Zmijewski J W, Moellering D R, Le Goffe C, Landar A, Ramachandran A, Darley-Usmar V M. Oxidized LDL induces mitochondrially associated reactive oxygen/nitrogen species formation in endothelial cells. Am J Physiol Heart Circ Physiol 2005; 289: H852–H861
   PubMed Web of Science ®Google Scholar